Novartis AG Current Tax Assets Current
Novartis AG (NVSEF) had Current Tax Assets Current of $205.00 million as of 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:CurrentTaxAssetsCurrent · last filed 2026-02-04
- 2025-12-31: Current Tax Assets Current $205.00M.
- 2025-06-30: Current Tax Assets Current $120.00M.
- 2024-12-31: Current Tax Assets Current $133.00M.
- 2024-06-30: Current Tax Assets Current $252.00M.
| Period end | Current Tax Assets Current |
|---|---|
| 2025-12-31 | $205.00M 20-F · filed 2026-02-04 |
| 2025-06-30 | $120.00M 6-K · filed 2025-07-17 |
| 2024-12-31 | $133.00M 20-F · filed 2026-02-04 |
| 2024-06-30 | $252.00M 6-K · filed 2024-07-18 |
| 2023-12-31 | $426.00M 20-F · filed 2025-01-31 |
| 2023-06-30 | $348.00M 6-K · filed 2023-07-18 |
| 2022-12-31 | $268.00M 20-F · filed 2024-01-31 |
| 2022-06-30 | $267.00M 6-K · filed 2022-07-19 |
| 2021-12-31 | $278.00M 20-F/A · filed 2023-05-15 |
| 2021-06-30 | $254.00M 6-K · filed 2021-07-21 |
| 2020-12-31 | $239.00M 20-F · filed 2022-02-02 |
| 2020-06-30 | $308.00M 6-K · filed 2020-07-21 |
| 2019-12-31 | $254.00M 20-F · filed 2021-01-26 |